Investor Presentation • Nov 15, 2023
Investor Presentation
Open in ViewerOpens in native device viewer
1
November 16th, 2023
Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forwardlooking statements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forwardlooking statements. The Company undertakes no obligation about the contents nor to update the forwardlooking statements to reflect events or circumstances that may arise after the date hereof.
Hi-Tech industrial group providing laser solutions with proprietary technologies and know how developed over 40 years
Listed on Milan's Stock Exchange Star segment since year 2000 and member of Euronext Tech Leaders
Active worldwide on several laser application segments andmarkets…
…progressively widening its worldwide presence achieving continuous growth over the years
Our energy based systems improve people's well-being and life quality.
In the SURGICAL SECTOR, our minimally invasive technology systems minimize pain, side effects and risks of surgical procedures and hospitalization days.
In the AESTHETIC SECTOR, our systems satisfy the growing desire of individuals to improve their appearance also reducing pathological or painful imperfections.
Our LASER CUTTING and MARKING SYSTEMS Improve the productivity of our customers manufacturing plants also limiting the environmental impact of manufacturing processes minimizing waste, fumes generatedby the process, use of chemical additives, andallowing to eliminate the need for inks, solvents or glues within the process.
Our LASER SYSTEMS PRESERVE artworks of the universal heritage of our communities.
Photovoltaic systems active in 21
4New plants installed in 22
9%Self-generated energy or from renewable sources
7
Production of CO2 lasers for dermatology, surgery and therapy
Incorporation of El.En.S.n.c
Development of short pulse Nd:YAG lasers for dentistry and minimally invasive surgery treatments
Incorporation of Deka MELA S.r.l., Lasit S.p.A. eCutlite Penta S.r.l.
Smartepil (Deka Mela S.r.l.) - first long pulse Nd:Yag laser for dermatology and hair removal
El.En.S.p.A.listed on the italian stock market
Smartlipo (Deka Mela S.r.l.laserlipolisi®: localized removal of adipose deposits with minimally invasive treatment
Acquisition of Cynosure Inc.
Smartxide DOT® Therapy (Deka Mela S.r.l.) dermatological surgery, anti-aging treatments,removal of pigmented lesions and scars
Acquisition of Asclepion GmbH
2004
Acquisition of Quanta System
Acquisition of Asa
Cynosure IPO on Nasdaq
Incorporation of a JV in China: Wuhan Penta Chutian Co.Ltd
Incorporation of Cutlite Do Brasil Alta Tecnologia Ltda
Mediostar XT (Asclepion GmbH) esthetics and hair removal.
Industrial sector El.En.– creation of the BLADE RF CO2BLADE RF laser sources family
Litho (Quanta System S.p.A.) surgical, treatment of kidney stones
Plus RF (Cutlite Penta S.r.l.) with RF El.En. sources for metacrilate and wood cutting systems
Incorporation of Esthelogue S.r.l.
Smartxide2 (Deka Mela S.r.l.) laser system with CO2 radio frequency (RF) laser sources for dermatological surgery and aesthetics
2011
Mediostar Next (Asclepion GmbH) aesthetics, hair removal
Monna Lisa TouchTM (Deka Mela S.r.l.) for the treatment of vaginal atrophy
Cyber (Quanta System S.p.A.) surgery, Lithotripsy and BPH
Incorporation of second JV Penta Laser Equipment (Wenzhou) Co.Ltd
Motus AX with Moveo (Deka Mela S.r.l.) hair removal,removal of pigmented lesions
Juliet® (Asclepion GmbH) for the treatment of vaginal atrophy
Deka M.E.L.A.S.r.l.and Quanta SystemS.p.A.join their commercial brand names intoReinassance® for the Italian market
The Chinese subsidiary Penta Laser Equipment (Wenzhou) Co.Ltd incorporates Penta Laser Technology (Shangdong) Co.Ltd
Acquisition by Quanta System of Galli S.r.l. a precision mechanical components manufacturing facility.
Bolt (Penta Chutian e Wenzhou - China) enhanced system for laser metal cutting
Discovery Pico (Quanta System S.p.A.) tattoo and pigmented lesions removal and dermatological treatments
HIRO TT (ASA S.r.l.) painful pathologies of the muscle and skeleton
Fiber Plus (Cutlite Penta S.r.l.) first metal cutting laser system equipped with fiber laser source
Industrial sector RF 1222 CO2 RF laser source "The Big Boy"
ONDA Coolwaves®(Deka Mela S.r.l.) the first microwaves technology system for body contouring
Schwarzy (magnetotherapy) RedTouch (dermatology) Again (hair removal)Dr.Arnold(magnetotherapy)
Lasit Laser Polska incorporated by Lasit in Poland
Glide (dermatology) Chrome Laser Station(dermatology)
9
| 2 0 2 8 |
|---|
| 2 0 2 9 o |
| 2 0 3 2 o |
| 2 0 3 0 o |
With an estimated market size of ≃\$5 Bln in 2021 including:
Research and Markets CAGR 15,2% to 2027 The business research company CAGR 19,1% to 2027
Again Pro Motus
19
Unique high end system for laser tattoo removal
The ultimate multi application and multi technology platform
The system for neocollagenesis and tissue regeneration
One of the main worldwide players in high power medical fiber lasers
Our novel disruptive technology for the most effective stones micro fragmentation
Novel CO2 device for dermatology and gynecology featuring an additional 1540nm laser source
MiS (MLS Family) For degenerative neuropathies
12 kW Average power in 2022 sales
40 kW systems installed in 2022
| '0 E 0 0 u r o |
/ / 3 1 1 2 2 1 |
% | / / 3 1 1 2 2 2 |
% | % V a r. |
|---|---|---|---|---|---|
| d d i t u n a u e |
|||||
| d l i M e c a |
3 2 9 0 1 1. |
% 5 4, 5 |
3 8 2 0 6 3 |
6, % 5 7 |
2 2, % 7 |
| d l I i t n u s r a |
2 6 0 1 1 2 |
4 % 5, 5 |
2 9 1. 1 8 5 |
4 3, 3 % |
1 2, 1 % |
| R e v e n u e s |
5 7 1 4 0 2 |
1 0 0 0 % , |
6 7 3 5 8 1 |
1 0 0 0 % , |
1 7 9 % , |
| i G r o s s m a r g n |
2 1 2 0 7 3 |
% 3 7 1 , |
2 4 9 6 9 5 |
% 3 7 1 , |
% 1 7 7 , |
| i O E t p e r a n g x p e n s e s |
4 7 8 1 2 |
% 8 4 , |
5 6 2 5 0 |
% 8 4 , |
% 1 7 6 , |
| f f S t a e s p e n s e s |
8 4 1 0 7 |
1 4 % 7 , |
9 8 1 9 4 |
1 4 6 % , |
1 6 % 7 , |
| E B I T D A |
8 0 0 9 1 |
1 4 0 % , |
9 5 2 5 1 |
1 4 1 % , |
1 8 9 % , |
| l D t. e p r. a m o r a c c r u a s , , |
1 5 2 3 4 |
% 2 7 , |
1 4 2 5 0 |
% 2 1 , |
% 6 5 - , |
| E B I T |
6 8 8 4 5 |
% 1 1, 4 |
8 0 0 1 1 |
2 0 % 1 , |
2 9 % 4 , |
| f ( ) h N i i t e n a n c. n c o m e c a r g e s |
1 7 5 2 |
0 3 % , |
( ) 1 9 3 4 |
0 3 % - , |
|
| h ( ) O i t t e r n c o m e e x p e n s e n e |
( ) 1 8 5 |
0 0 % , |
( ) 7 9 |
0 0 % , |
5 7 5 % - , |
| E B T |
6 6 4 2 4 |
% 1 1, 6 |
7 8 9 8 8 |
% 1 1, 7 |
% 1 8 9 , |
| I t n c o m e a x e s |
3 0 0 1 7 |
3 0 % , |
9 9 3 1 5 |
3 0 % , |
3 % 1 5 , |
| M i i i t n o r e s |
3 6 8 8 |
0 6 % , |
3 9 2 5 |
0 6 % , |
6 4 % , |
| N E T I N C O M E |
4 5 4 3 6 |
% 8 0 , |
5 5 1 1 1 |
% 8 2 , |
% 2 1, 3 |
| / / 3 2 2 1 1 1 |
/ / 3 2 2 2 1 1 |
% V a r. |
|---|---|---|
| d t t r e s a e |
||
| 1 3 6 6 4 8 |
1 6 5 7 8 6 |
% 2 1 3 , |
| 1 4 4 6 4 1 |
2 0 0 5 3 6 |
% 3 8 6 , |
| ( 9 1 2 8 7 |
( 8 0 1 5 4 |
1 2 2 % - , |
| 6 6 1 1 5 7 |
3 6 3 7 5 |
3 9 % 4 - , |
| 1 8 0 7 6 |
1 8 0 7 7 |
% 0 0 , |
| 2 8 7 7 0 1 |
3 4 3 4 5 5 |
% 1 9 4 , |
| 1 7 1 9 3 5 |
2 6 8 0 9 2 |
5 5 9 % , |
| 2 3 % 5 , |
2 9 8 % , |
|
| % 3 7 7 , |
% 3 0 2 , |
|
| 2 3 1 5 0 |
2 8 5 1 4 |
|
| ) | ) |
| '0 E 0 0 r o u |
/ / 3 0 0 9 2 2 |
% | / / 3 0 0 9 2 3 |
% | % V a r. |
|---|---|---|---|---|---|
| d d i t u n a u e |
d d i t u n a u e |
||||
| d l M i e c a |
2 7 0 5 2 9 |
5 5, 9 % |
2 8 7 9 5 4 |
5 8, 4 % |
6, 4 % |
| d l I i t n s r a u |
2 1 3 8 2 0 |
% 4 4, 1 |
2 0 5 0 5 7 |
% 4 1, 6 |
% 4, 1 - |
| R e v e n u e s |
8 3 8 4 4 4 |
0 0 0 % 1 , |
9 3 0 4 1 1 |
0 0 0 % 1 , |
8 % 1, |
| G i r o s s m a r g n |
9 9 6 1 7 4 |
3 % 7 1 , |
8 2 1 7 1 1 |
3 8 0 % , |
3 % 4 , |
| O i E t p e r a n g x p e n s e s |
4 1 1 1 5 |
8 6 % , |
4 4 3 9 3 |
9 0 % , |
6 9 % , |
| f f S t a e s p e n s e s |
7 0 4 2 1 |
1 4 5 % , |
8 0 9 3 8 |
1 6 4 % , |
1 4 9 % , |
| E B I T D A |
6 7 5 6 4 |
% 1 3 9 , |
6 1 8 8 0 |
% 1 2 6 , |
% 8 4 - , |
| l D t. e p r. a m o r a c c r a s u , , |
9 6 4 0 |
% 2 0 , |
1 0 1 0 2 |
% 2 0 , |
% 4 8 , |
| E B I T |
5 7 9 2 4 |
% 1 2 0 , |
5 1 7 7 8 |
% 1 0 5 , |
% 1 0 6 - , |
| ( ) f h i i N t e n a n c. n c o m e c a r g e s |
( ) 7 |
0 0 % , |
( ) 8 6 6 |
0 2 % - , |
3 0 8 8 % 1 7 , |
| ( ) h O i t t e r n c o m e e x p e n s e n e |
3 | 0 0 % , |
( ) 2 4 |
0 0 % , |
|
| E B T |
9 2 0 5 7 |
2 0 % 1 , |
0 8 0 5 7 |
0 3 % 1 , |
2 2 % 1 - , |
| / / 3 1 1 2 2 2 |
/ / 3 0 0 9 2 3 d d i t n a e u u |
||||
| f l i i i i N t t e n a n c a p o s o n |
7 5 3 6 3 |
3 2 0 8 9 |
| '0 0 0 E u r o |
Q 3 2 0 2 2 - |
% Q 3 2 0 2 3 - |
% | % V a r. |
|
|---|---|---|---|---|---|
| d d i t u n a u e |
d d i t u n a u e |
||||
| R e e n e s v u |
1 5 7 3 7 4 |
% 1 0 0 0 , |
1 4 7 3 8 6 |
% 1 0 0 0 , |
% 6 3 - , |
| i G r o s s m a r g n |
5 7 6 4 1 |
3 6 6 % , |
5 5 7 3 8 |
3 7 8 % , |
3 3 % - , |
| O i E t p e r a n g x p e n s e s |
1 3 8 6 4 |
8 8 % , |
1 3 2 7 7 |
9 3 % , |
0 % 7 - , |
| f f S t a e s p e n s e s |
2 3 4 3 9 |
% 1 4 9 , |
2 5 7 4 1 |
% 1 7 5 , |
% 9 8 , |
| E B I T D A |
2 0 3 3 7 |
% 1 2 9 , |
1 6 2 2 6 |
% 1 1 0 , |
% 2 0 2 - , |
| l D t e p r. a m o r a c c r a s u , ., |
3 8 0 4 |
% 2 4 , |
3 3 2 2 |
% 2 3 , |
% 1 2 7 - , |
| E B I T |
1 6 3 3 5 |
1 0 % 5 , |
1 2 9 0 3 |
8 8 % , |
2 2 0 % - , |
| f ( ) h i i N t e n a n c n c o m e c a r g e s |
( ) 2 6 1 |
0 2 % - , |
6 2 1 |
0 % 1 , |
|
| ( ) h i O t t e r n c o m e e x p e n s e n e |
( ) 4 |
% 0 0 , |
( ) 3 8 |
% 0 0 , |
% 7 5 4 9 , |
| E B T |
1 6 2 6 7 |
1 0 3 % , |
1 3 0 2 8 |
8 8 % , |
1 9 9 % - , |
| k h l 's h d i S E t t o c o e r q u y p e r s a r e |
4 5 , |
|---|---|
| / k l d i j. P B V A r c e o o a e u |
2 0 , |
| / ( ) 9 0 % E V E B I T E B I T |
1 0 9 , |
| / ( ) l l E V S 9 0 % S a e s a e s |
1, 1 |
| l. k C E E M t n a r e a p |
3 0 9 @ 7 , |
€ 9 1 4 , |
|---|---|---|
| f l i i i i N t t e n a n c a p o s o n |
@ 3 2 1 , |
/ / 3 0 0 9 2 3 |
| / l l i i i F t t t n a n c a n v e s m e n s m e r m |
@ 2 3 6 , |
/ / 3 0 0 9 2 3 |
| i l E V t n e r p r s e a u e |
6 7 5 2 , |
| h , Se 3 0 2 0 2 3 t. t p |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ic Pr No 1 5, e o n v. |
Re ve nu e |
% Va r. |
E B I T |
% E B I T |
M K. Ca p. |
E V |
/ Sa le E V s |
/ E V E B I T |
/ k P Bo o |
|
| / d ica l he ic M Ae t t e s |
2 0 2 3 |
Re v. |
( *) |
( *) |
lu Va e |
|||||
| ( ) Cu 2 te ra |
\$ 2, 2 3 |
\$ 6 1 1 |
% -5 |
\$ ( ) 3 5 |
6 % -4 |
\$ 4 4 |
\$ 2 5 1 |
1, 1 |
n. a. |
n. a. |
| de In M o |
\$ 2 0, 9 7 |
\$ 3 6 5 |
1 4 % |
\$ 1 4 4 |
4 0 % |
\$ 1. 7 4 0 |
\$ 1. 0 6 7 |
2, 2 |
5, 6 |
2, 4 |
| l h Be He ty t au a |
\$ 1, 3 9 |
\$ 3 0 1 |
% 1 3 |
\$ ( ) 1 1 3 |
% -3 7 |
\$ 1 8 5 |
\$ 3 7 7 |
0, 9 |
n. a. |
2, 1 |
| ( ) Ve 2 nu s |
\$ 1, 8 3 |
\$ 4 1 |
-2 4 % |
\$ ( ) 1 4 |
-3 4 % |
\$ 1 0 |
\$ 8 8 |
1, 1 |
n. a. |
n. a. |
| d l ( ) S isr M ica 2 am e |
\$ 0, 7 4 |
\$ 1 7 2 |
-2 % |
\$ 2 2 |
1 3 % |
\$ 3 4 7 |
\$ 3 3 3 |
1, 0 |
7, 7 |
0, 8 |
| du ia l In tr s |
||||||||||
| ho I G ics Co P P to n |
\$ 9 2 6 5, |
\$ 9 8 9 |
-1 0 % |
\$ 2 0 3 |
2 1 % |
\$ 4. 4 0 7 |
\$ 3. 4 0 6 |
2, 6 |
1 2, 6 |
1, 9 |
| 's Ha La n se r |
¥ 2 2, 9 4 |
¥ 9. 3 4 4 |
-1 1 % |
¥ 5 9 9 |
6 % |
¥ 2 4. 0 2 0 |
¥ 2 3. 7 0 6 |
1, 9 |
2 9, 8 |
1, 4 |
| ( ) ic 2 By tr s on |
C 9 6 H F 4 |
C 6 8 H F 4 |
3 % |
C 2 H F 5 |
% 5 |
C 9 0 6 H F |
C 9 H F 5 1 |
0, 6 |
0, 3 1 |
3 1, |
| l. ( ) E En 1 |
€ 9, 1 4 |
€ 9 3 4 |
2 % |
€ 2 5 |
% 1 1 |
€ 3 7 1 |
€ 6 7 5 |
1, 1 |
0, 9 1 |
2, 0 |
(1) EV and multiplies as for previous slide
(2) Financials on June 30th, 2023
(*) Revenue,Ebit and earnings annualized
44
El.En. S.P.A.Enrico RomagnoliInvestor Relations Managertel. +39 055-8826807E-mail: [email protected]
Financial Communication, IR and Press OfficeBianca Fersini Mastelloni - [email protected] Silvia Marongiu [email protected]. +39 06-69923324
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.